NASDAQ:SNOA Sonoma Pharmaceuticals Q4 2025 Earnings Results & Report $0.72 -0.09 (-10.83%) Closing price 04:00 PM EasternExtended Trading$0.72 -0.01 (-0.69%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sonoma Pharmaceuticals beat analyst earnings expectations but missed on revenue in its Q4 2025 results, released June 17, 2025. The company reported EPS of -$0.15 versus the -$0.73 consensus estimate, while revenue of $3.75 million fell short of the $4.44 million estimate by $690.00 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateJune 17, 2025TimeBefore Market Opens Sonoma Pharmaceuticals EPS ResultsActual EPS-$0.15Consensus EPS -$0.73Beat/MissBeat by +$0.58One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersSonoma Pharmaceuticals Revenue ResultsActual Revenue$3.75 millionExpected Revenue$4.44 millionBeat/MissMissed by -$690.00 thousandYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Sonoma Pharmaceuticals Q4 2025 Earnings FAQ Did Sonoma Pharmaceuticals beat earnings estimates for Q4 2025? Sonoma Pharmaceuticals (NASDAQ:SNOA) reported earnings of -$0.15 per share for Q4 2025, beating the consensus estimate of -$0.73. The report was announced on Tuesday, June 17, 2025. What was Sonoma Pharmaceuticals' revenue for Q4 2025? Sonoma Pharmaceuticals reported revenue of $3.75 million for Q4 2025, against a consensus estimate of $4.44 million. Sonoma Pharmaceuticals Earnings HeadlinesSonoma Pharmaceuticals Cancels Adjourned Special Stockholder MeetingAugust 19, 2026 | tipranks.comSonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly RevenueAugust 6, 2026 | benzinga.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.November 20 at 1:00 AM | Porter & Company (Ad)Sonoma Pharmaceuticals Expands At-the-Market Equity Offering CapacityJune 18, 2026 | tipranks.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial ResultsJune 16, 2026 | finanznachrichten.deWhat's going on with Sonoma Pharma stock Monday?April 27, 2026 | msn.comSee More Sonoma Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sonoma Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sonoma Pharmaceuticals and other key companies, straight to your email. Email Address About Sonoma PharmaceuticalsSonoma Pharmaceuticals (NASDAQ:SNOA) develops and markets products based on its stabilized hypochlorous acid technology for human and animal health. Its product portfolio includes solutions and gels for wound care, skin conditions, eye care and other hygiene applications. The company’s offerings include Microcyn-branded products, which are used in areas such as wound management and dermatology, as well as products for veterinary care. Sonoma sells its products through commercial partners and distributors in the United States and international markets. The company was formerly known as Oculus Innovative Sciences and adopted the Sonoma Pharmaceuticals name in 2016. Its business has since focused on developing and commercializing hypochlorous acid-based products for healthcare and related markets.View Sonoma Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.